Work Experiences of Patients Receiving Palliative Care at a Comprehensive Cancer Center: Exploratory Analysis

Glare, Paul; Nikolova, Tanya; Alickaj, Alberta; Patil, Sujata; Blinder, Victoria S.

doi:10.1089/jpm.2016.0478

Cited by 13 publications

(17 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is understandable, given that the patients who received chemotherapy or radiotherapy likely had more symptoms and a higher disease burden than those treated with hormonal therapy. This is also consistent with the reports of others, in which having more substantial symptoms was associated with lower employment rates [19,23,35], and in which receiving more courses of chemotherapy or radiotherapy was associated with a lower likelihood of current employment [2,35].…”

Section: Discussionsupporting

confidence: 92%

“…Patients in Sweden with illnesses like mBC are expected to work to the extent that they are able [17,18]. As patients with mBC become more likely to enjoy good health for a period of time [11,12], the ability to return to work may contribute to their sense of well-being [19].…”

Section: Introductionmentioning

confidence: 99%

“…Often forced because of illness to leave full-time work, many cancer survivors eventually desire to return to paid work or other meaningful activities that can provide them with daily structure [20,21], and this may also be the case for the subset of patients who are receiving palliative treatment for incurable cancer [2]. Recent studies suggest that factors such as lower performance scores, higher symptom burdens, belonging to ethnic minority groups, and lack of capacity to work full-time have been associated with lower rates of employment in women with mBC [19,22,23]. However, it is largely unknown how much women use sickness bene ts after their mBC diagnosis, and what the factors are that in uence this.…”

Section: Introductionmentioning

confidence: 99%

“…Many cancer survivors are forced because of illness to leave full‐time work (Cardoso et al, 2016; Stergiou‐Kita et al, 2014; Tamminga et al, 2012). For women with mBC, there are specific patient‐ and tumour‐related factors that can impact their prognosis and employment status, including age, performance status, sites of metastases and disease‐free intervals between primary BC and metastases (Gernaat et al, 2020), as well as minority ethnicity, symptom burdens and capacity to work full‐time (Glare et al, 2017; Samuel et al, 2020; Tevaarwerk et al, 2016).…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Use of sickness benefits by patients with metastatic breast cancer—A Swedish cohort study

Altena

Gernaat

Wilking

et al. 2022

European J Cancer Care

View full text Add to dashboard Cite

Objective: The objective of this study is to determine the prevalence and predictors of sickness absence (SA) and disability pension (DP) in women with metastatic breast cancer (mBC).Methods: Data were obtained from Swedish registers concerning 1,240 adult women diagnosed 1997-2011 with mBC, from 1 year before (yÀ1) to 2 (y1) and 2 (y2) years after diagnosis. SA and DP prevalence was calculated. Odds ratios (AOR) were determined for factors associated with using long-term (SA > 180 days or DP > 0 days) sickness benefits.Results: Prevalence of SA and DP was 56.0% and 24.8% during yÀ1, 69.9% and 28.9% during y1, and 64.0% and 34.7% during y2, respectively. Odds of using longterm sickness benefits were higher y1 and y2 in patients using long-term sickness benefits the year before diagnosis (AOR = 3.82, 95% CI 2.91-5.02; AOR = 4.31, 95% CI 2.96-6.29, respectively) and y2 in patients with mBC diagnosis 1997-2000 (AOR = 1.84, 95% CI 1.10-3.08) and using long-term sickness benefits the year after diagnosis (AOR = 22.10, . Conclusions:The prevalence of sickness benefit utilisation was high and increased after mBC diagnosis, particularly for patients using long-term sickness benefits prior to diagnosis. Additional study is needed to determine factors that might reduce the need for sickness benefits and enhance work ability in these patients.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Use of sickness benefits by patients with metastatic breast cancer—A Swedish cohort study

Altena

Gernaat

Wilking

et al. 2022

European J Cancer Care

View full text Add to dashboard Cite

show abstract

“…[12][13][14][15] The current study findings in younger breast cancer survivors are consistent with prior studies on the economic impact on breast cancer survivors of all age groups (such as job discontinuation and decreased working hours). [16][17][18][19][20][21][22] Several studies of breast cancer survivors of all ages have documented a substantial employment disruption over the course of the diagnosis and treatment process. 16,21 Being employed improves the quality of life of cancer patients in numerous ways; for example, it is a source of income, health insurance, social interactions, and distraction.…”

Section: Discussionmentioning

confidence: 99%

Young Breast Cancer Survivors: Employment Experience and Financial Well-Being

Tangka¹,

Subramanian

Jones

et al. 2020

View full text Add to dashboard Cite

The economic burden of breast cancer for women under 50 in the United States remains largely unexplored, in part because young women make up a small proportion of breast cancer cases overall. To address this knowledge gap, we conducted a web-based survey to compare data from breast cancer survivors 18–39 years of age at first diagnosis and 40–49 years of age at first diagnosis. We administered a survey to a national convenience sample of 416 women who were 18–49 years of age at the time of their breast cancer diagnosis. We analyzed factors associated with financial decline using multivariate regression. Survivors 18–39 years of age at first diagnosis were more likely to report Stage II–IV breast cancer (P<0.01). They also quit their jobs more often (14.6%) than older survivors (4.4%; P<0.01) and faced more job performance issues (55.7% and 42.8%, respectively; P=0.02). For respondents in both groups, financial decline was more likely if the survivor had at least one comorbid condition (odds ratios: 2.36–3.21) or was diagnosed at Stage II–IV breast cancer (odds ratios: 2.04–3.51).

show abstract

Planning for return to work during the first year after breast cancer metastasis: A Swedish cohort study

et al. 2023

View full text Add to dashboard Cite

Background Planning for return to work (RTW) is relevant among sub‐groups of metastatic breast cancer (mBC) survivors. RTW and protective factors for RTW in patients with mBC were determined. Methods Patients with mBC, ages 18–63 years, were identified in Swedish registers, and data were collected starting 1 year before their mBC diagnosis. The prevalence of working net days (WNDs) (>90 and >180) during the year after mBC diagnosis (y1) was determined. Factors associated with RTW were assessed using regression analysis. The impact of contemporary oncological treatment of mBC on RTW and 5‐year mBC‐specific survival was compared between those diagnosed in 1997–2002 and 2003–2011. Results Of 490 patients, 239 (48.8%) and 189 (36.8%) had >90 and >180 WNDs, respectively, during y1. Adjusted odds ratios (AORs) of WNDs >90 or >180 during y1 were significantly higher for patients with age ≤50 years (AOR180 = 1.54), synchronous metastasis (AOR90 = 1.68, AOR180 = 1.67), metastasis within 24 months (AOR180 = 1.51), soft tissue, visceral, brain as first metastatic site (AOR90 = 1.47) and sickness absence <90 net days in the year before mBC diagnosis, suggesting limited comorbidities (AOR90 = 1.28, AOR180 = 2.00), respectively. Mean (standard deviation) WNDs were 134.9 (140.1) and 161.3 (152.4) for patients diagnosed with mBC in 1997–2002 and 2003–2011, respectively (p = 0.046). Median (standard error) mBC‐specific survivals were 41.0 (2.5) and 62.0 (9.6) months for patients diagnosed with mBC in 1997–2002 and 2003–2011, respectively (p < 0.001). Conclusions RTW of more than 180 WNDs was associated with younger age, early development of metastases and limited comorbidities during the year before the diagnosis of mBC. Patients diagnosed with mBC in 2003 or later had more WNDs and better survival than those diagnosed earlier.

show abstract

Work Experiences of Patients Receiving Palliative Care at a Comprehensive Cancer Center: Exploratory Analysis

Abstract: Work may be an important issue for some palliative care patients. Additional research is needed to facilitate ongoing employment for those who wish or need to continue working.

Cited by 13 publications

References 18 publications

Use of sickness benefits by patients with metastatic breast cancer—A Swedish cohort study

Use of sickness benefits by patients with metastatic breast cancer—A Swedish cohort study

Young Breast Cancer Survivors: Employment Experience and Financial Well-Being

Planning for return to work during the first year after breast cancer metastasis: A Swedish cohort study

Contact Info

Product

Resources

About